Yüklüyor......
Amyloid precursor protein selective gamma-secretase inhibitors for treatment of Alzheimer's disease
INTRODUCTION: Inhibition of gamma-secretase presents a direct target for lowering Aβ production in the brain as a therapy for Alzheimer's disease (AD). However, gamma-secretase is known to process multiple substrates in addition to amyloid precursor protein (APP), most notably Notch, which has...
Kaydedildi:
Asıl Yazarlar: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Materyal Türü: | Artigo |
Dil: | Inglês |
Baskı/Yayın Bilgisi: |
BioMed Central
2010
|
Konular: | |
Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3031881/ https://ncbi.nlm.nih.gov/pubmed/21190552 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/alzrt60 |
Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|